Skip to main content
. 2017 Mar 3;195(3):281–288. doi: 10.1007/s00408-017-9990-8

Table 2.

Distribution of pneumonia events and incidence rates

Treatment Events Years in study Incidence rate Incident rate ratio (95% CI) p value
(A)
 No ICS 383 6885 0.056 Reference
 ICS 738 10,836 0.068 1.22 (1.08, 1.38) 0.012
(B)
 FP 437 5685 0.077 1.38 (1.20, 1.58) <0.001
 Other ICS 301 5151 0.058 1.05 0.52
 No ICS 383 6885 0.056 Reference
(C)
 FP/Plac 220 2720 0.081 1.45 (1.19, 1.77) <0.001
 FP/tio 217 2964 0.073 1.31 (1.08, 1.60) 0.006
 Other ICS/plac 153 2461 0.062 1.12 (0.90, 1.38) 0.29
 Other ICS/tio 148 2690 0.055 0.99 (0.79, 1.23) 0.94
 No ICS/plac 184 3317 0.055 Reference
 No ICS/tio 199 3567 0.056 1.00 (0.82, 1.22) 0.95

ICS Inhaled corticosteroids, FP fluticasone propionate, tio tiotropium, plac placebo